BioCryst Pharmaceuticals
BCRX
$4.16
Share price
0.00%
Change (1 day)
-44.75%
Change (1 year)
Categories
EPS for BioCryst Pharmaceuticals (BCRX)
EPS in 2023 (TTM): -$1.25
According to BioCryst Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$1.25. In 2022 the company made an earnings per share (EPS) of -$1.33 a decrease over its 2021 EPS that were of -$1.03.
EPS history for BioCryst Pharmaceuticals from 2001 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$1.25 | -6.02% |
| 2022 | -$1.33 | 29.13% |
| 2021 | -$1.03 | -4.63% |
| 2020 | -$1.08 | 10.2% |
| 2019 | -$0.98 | 0% |
| 2018 | -$0.98 | 25.64% |
| 2017 | -$0.78 | 4% |
| 2016 | -$0.75 | 27.12% |
| 2015 | -$0.59 | -13.24% |
| 2014 | -$0.68 | 23.64% |
| 2013 | -$0.55 | -30.38% |
| 2012 | -$0.79 | -37.3% |
| 2011 | -$1.26 | 65.79% |
| 2010 | -$0.76 | 117.14% |
| 2009 | -$0.35 | -46.15% |
| 2008 | -$0.65 | -26.97% |
| 2007 | -$0.89 | -40.67% |
| 2006 | -$1.50 | 48.51% |
| 2005 | -$1.01 | 1% |
| 2004 | -$1.00 | 38.89% |
| 2003 | -$0.72 | -25% |
| 2002 | -$0.96 | 231.03% |
| 2001 | -$0.29 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Gilead Sciences GILD | $4.39 | -451.20% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $3.50 | -380.06% | 🇬🇧 UK |
 Sarepta Therapeutics
SRPT | -$7.83 | 526.40% | 🇺🇸 USA |
 Repligen
RGEN | $2.09 | -267.20% | 🇺🇸 USA |
 Novavax NVAX | -$7.19 | 475.20% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | -$2.40 | 92.00% | 🇺🇸 USA |
 NanoViricides NNVC | -$0.59 | -52.80% | 🇺🇸 USA |
 Cel-Sci
CVM | -$0.77 | -38.40% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | -$12.08 | 866.40% | 🇺🇸 USA |